
Number of publications published per year by Villanueva, Augusto. (Source : PubMed)

Distribution of publications types for Villanueva, Augusto. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
J. Hepatol.
2010;52;4

miRNA delivery: emerging therapy for hepatocellular carcinoma.
Gastroenterology
2010;138;3
Migrating azygos vein and vanishing azygos lobe: MDCT findings.
AJR Am J Roentgenol
2010;194;3
Cell death causes relocalization of photosensitizing fluorescent probes.
Acta Histochem.
2010
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.
Semin. Liver Dis.
2010;30;1

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
Annu. Rev. Med.
2010;61

Molecular mechanisms behind the resistance of cisplatin in germ cell tumours.
Clin Transl Oncol
2009;11;12
Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area.
Shock
2009;32;6
Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Cancer Res.
2009;69;21


Lymphotoxins: new targets for hepatocellular carcinoma.
Cancer Cell
2009;16;4
[ See timeline ] [ See all publications ]
means that Villanueva, Augusto has 15 papers cited a least 15 times - methodology
HCC Translational Research Laboratory, Barcelona-Clínic Liver Cancer Group, Institut d'Investigacions Biomediques Agusto Pi i Sunyer (IDIBAPS), Liver Unit, Hospital Clinic, Barcelona, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.